Vivimed Labs has informed about a Press Release dated July 22, 2016 titled ‘Klar Sehen, a wholly owned subsidiary of Vivimed announces the sale of certain products along with associated trademarks Total consideration for the identified products and trademarks is Rs 730 million.’
The above information is a part of company’s filings submitted to BSE.